SIBN Si-Bone Inc

USD 16.37 0.55 3.476612
Icon

Si-Bone Inc (SIBN) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 16.37

+0.55 (+3.48)%

USD 0.66B

0.52M

USD 25.14(+53.59%)

N/A

Icon

SIBN

Si-Bone Inc (USD)
COMMON STOCK | NSD
USD 16.37
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.66B

N/A

USD 16.37

Si-Bone Inc (SIBN) Stock Forecast

Show ratings and price targets of :
USD 25.14
(+53.59%)

Based on the Si-Bone Inc stock forecast from 5 analysts, the average analyst target price for Si-Bone Inc is USD 25.14 over the next 12 months. Si-Bone Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Si-Bone Inc is Slightly Bearish, which is based on 3 positive signals and 4 negative signals. At the last closing, Si-Bone Inc’s stock price was USD 16.37. Si-Bone Inc’s stock price has changed by +4.27% over the past week, -5.65% over the past month and -15.88% over the last year.

No recent analyst target price found for Si-Bone Inc
No recent average analyst rating found for Si-Bone Inc

Company Overview Si-Bone Inc

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult...Read More

https://si-bone.com

471 El Camino Real, Santa Clara, CA, United States, 95050

344

December

USD

USA

Adjusted Closing Price for Si-Bone Inc (SIBN)

Loading...

Unadjusted Closing Price for Si-Bone Inc (SIBN)

Loading...

Share Trading Volume for Si-Bone Inc Shares

Loading...

Compare Performance of Si-Bone Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SIBN

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Si-Bone Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DXCM
DexCom Inc -0.78 (-0.56%) USD51.34B 103.24 55.96

ETFs Containing SIBN

Symbol Name SIBN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Si-Bone Inc (SIBN) Stock

Based on ratings from 5 analysts Si-Bone Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 7 buy, sell and hold ratings.

Unfortunately we do not have enough data on SIBN's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for SIBN is USD 25.14 over the next 12 months. The maximum analyst target price is USD 26 while the minimum anlayst target price is USD 25.

Unfortunately we do not have enough data on SIBN's stock to indicate if its overvalued.

The last closing price of SIBN's stock was USD 16.37.

The most recent market capitalization for SIBN is USD 0.66B.

Based on targets from 5 analysts, the average taret price for SIBN is projected at USD 25.14 over the next 12 months. This means that SIBN's stock price may go up by +53.59% over the next 12 months.

We can't find any ETFs which contains Si-Bone Inc's stock.

As per our most recent records Si-Bone Inc has 344 Employees.

Si-Bone Inc's registered address is 471 El Camino Real, Santa Clara, CA, United States, 95050. You can get more information about it from Si-Bone Inc's website at https://si-bone.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...